Kelly Furness - Concepedia

Author

Kelly Furness

Eli Lilly (United States)

Also Known As

Kelly Furness, Kelly W. Furness

Publications

495

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of Kansas

About

Kelly Furness is an author at Eli Lilly (United States) specializing in drug discovery, medicinal chemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	317
2	Biomolecular Engineering	4	4	215
3	Engineering	3	3	156
4	Natural Sciences	2	2	159
5	Biochemistry	2	2	159

Kelly Furness

Publications

491

Citations

H-Index

Page 1

	Year	Citations
Asymmetric Schmidt Reaction of Hydroxyalkyl Azides with Ketones Kiran Sahasrabudhe, Vijaya Gracias, Kelly Furness, Journal of the American Chemical Society Novel OrganocatalystsEngineeringAlkene MetathesisStereoelectronic FactorsOrganic Chemistry	2003	107
Substituted 3-Imidazo[1,2-<i>a</i>]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino- [6,7,1-<i>hi</i>]indol-7-yl)pyrrole-2,5-diones as Highly Selective and Potent Inhibitors of Glycogen Synthase Kinase-3 Thomas A. Engler, James R. Henry, Sushant Malhotra, Journal of Medicinal Chemistry Insulin ReceptorPharmaceutical ChemistryInsulin SignalingType Ii DiabetesMolecular Pharmacology	2004	100
The development of potent and selective bisarylmaleimide GSK3 inhibitors Thomas A. Engler, Sushant Malhotra, Timothy P. Burkholder, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicinePharmacotherapyAnti-cancer AgentDrug Development	2005	60
Synthesis and Evaluation of Peptidyl Michael Acceptors That Inactivate Human Rhinovirus 3C Protease and Inhibit Virus Replication Jian-she Kong, Shankar Venkatraman, Kelly Furness, Journal of Medicinal Chemistry Bioorganic ChemistryImmunologyMolecular BiologyAntiviral DrugViral Structural Protein	1998	59
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles Thomas A. Engler, Kelly Furness, Sushant Malhotra, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicinePharmacological AgentPharmacologyPharmaceutical Chemistry	2003	59
Synthetic Approaches to Indolo[6,7-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazoles: Potent Cyclin D1/CDK4 Inhibitors Margaret M. Faul, Thomas A. Engler, Kevin A. Sullivan, The Journal of Organic Chemistry Medicinal ChemistryEngineeringMedicineDrug DiscoverySynthetic Approaches	2004	39
1,7-Asymmetric Induction in a Nitrogen Ring Expansion Process Facilitated by in Situ Tethering Kelly Furness, Jeffrey Aubé Organic Letters	1999	34
Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor Aruna Wijeratne, Junpeng Xiao, Christopher T. Reutter, ACS Medicinal Chemistry Letters	2018	23
An improved method for direct conversion of heteroaryl-aldehydes to heteroaryl-acetonitriles Thomas A. Engler, Kelly Furness, Sushant Malhotra, Tetrahedron Letters Direct ConversionEngineeringOrganic ChemistryCatalysisStereoselective Synthesis	2003	10

Page 1